Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Tuesday, April 21, 2015 12:22:15 PM
bearish
## source: finance.yahoo.com
Tue, 21 Apr 2015 13:47:03 GMT ~ Hunt for Deadly Breast Cancer Genes Pools Thousands of Women
read full: http://finance.yahoo.com/news/hunt-deadly-breast-cancer-genes-040117871.html
*********************************************************
Tue, 21 Apr 2015 11:28:00 GMT ~ Startup Pledges To Cut Cost Of Breast Cancer Genetic Testing From $4000 To $249
read full: http://www.forbes.com/sites/matthewherper/2015/04/21/start-up-pledges-to-cut-cost-of-breast-cancer-genetic-testing-from-4000-to-249/?utm_campaign=yahootix&partner=yahootix
*********************************************************
Tue, 21 Apr 2015 05:46:13 GMT ~ Color Genomics Sells $249 Breast Cancer Gene Test to Masses
read full: http://finance.yahoo.com/news/color-genomics-sells-249-breast-054613173.html
*********************************************************
Tue, 21 Apr 2015 04:01:00 GMT ~ Quest Diagnostics, French agency seek to expand breast cancer gene database
read full: http://finance.yahoo.com/news/quest-diagnostics-french-agency-seek-040100912.html
*********************************************************
Thu, 09 Apr 2015 13:45:24 GMT ~ Cowen Thinks 3 Life Science Stocks Can Beat Earnings Estimates
read full: http://247wallst.com/healthcare-business/2015/04/09/cowen-thinks-3-life-science-stocks-can-beat-earnings-estimates/
*********************************************************
$MYGN charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$MYGN company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/MYGN/company-info
Ticker: $MYGN
OTC Market Place: Not Available
CIK code: 0000899923
Company name: Myriad Genetics, Inc.
Incorporated In: DE, USA
$MYGN share structure
## source: otcmarkets.com
Market Value: $2,501,207,122 a/o Apr 20, 2015
Shares Outstanding: 72,985,326 a/o Oct 30, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$MYGN extra dd links
Company name: Myriad Genetics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=MYGN+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=MYGN+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=MYGN+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/MYGN/news - http://finance.yahoo.com/q/h?s=MYGN+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/MYGN/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/MYGN/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=MYGN+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/MYGN
DTCC (dtcc.com): http://search2.dtcc.com/?q=Myriad+Genetics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Myriad+Genetics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Myriad+Genetics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/MYGN
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000899923&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/MYGN/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/MYGN/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=MYGN&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=MYGN
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/MYGN/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=MYGN+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=MYGN+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=MYGN
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=MYGN
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=MYGN+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/MYGN/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=MYGN+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/MYGN.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=MYGN
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/MYGN/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/MYGN/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/MYGN
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/MYGN
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/MYGN:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=MYGN
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=MYGN
$MYGN DD Notes ~ http://www.ddnotesmaker.com/MYGN
Recent MYGN News
- Reddit Rises 15% After First Quarterly Report, Upstart and Twilio Plunge Due to Weak Q2 Forecast, and More in Earnings • IH Market News • 05/08/2024 12:23:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 12:14:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:05:25 PM
- Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business • GlobeNewswire Inc. • 05/07/2024 01:00:00 PM
- Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 04/30/2024 08:05:00 PM
- Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen • GlobeNewswire Inc. • 04/16/2024 01:15:00 PM
- Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing • GlobeNewswire Inc. • 04/09/2024 12:00:00 PM
- Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date • GlobeNewswire Inc. • 03/22/2024 01:40:00 AM
- Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device • GlobeNewswire Inc. • 03/20/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:18:02 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 01:31:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:05:47 PM
- Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fo • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3 • GlobeNewswire Inc. • 02/27/2024 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:12:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:09:56 PM
- Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 • GlobeNewswire Inc. • 02/21/2024 09:05:00 PM
- Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health • GlobeNewswire Inc. • 02/15/2024 09:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:47:48 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:24:26 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/08/2024 03:14:32 PM
- Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics • GlobeNewswire Inc. • 02/01/2024 02:25:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:15:23 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM